Kanaly Trust’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$16K Sell
78
-3,026
-97% -$627K ﹤0.01% 475
2016
Q3
$715K Sell
3,104
-248
-7% -$60.6K 0.15% 75
2016
Q2
$775K Sell
3,352
-199
-6% -$45.9K 0.16% 74
2016
Q1
$952K Sell
3,551
-74
-2% -$21.2K 0.19% 62
2015
Q4
$1.13M Sell
3,625
-538
-13% -$160K 0.23% 54
2015
Q3
$1.13M Buy
+4,163
New +$1.28M 0.25% 54
2015
Q2
Sell
-3,972
Closed -$1.18M 872
2015
Q1
$1.18M Buy
3,972
+3,890
+4,744% +$1.11M 0.23% 59
2014
Q4
$21K Buy
82
+57
+228% +$14.2K ﹤0.01% 377
2014
Q3
$6K Buy
25
+2
+9% +$448 ﹤0.01% 530
2014
Q2
$5K Sell
23
-47
-67% -$9.73K ﹤0.01% 561
2014
Q1
$14K Buy
70
+6
+9% +$1.19K ﹤0.01% 445
2013
Q4
$11K Buy
+64
New +$10K ﹤0.01% 446

Other funds holding AGN

Kanaly Trust's AGN Position: Q4 2016 in Review

Kanaly Trust reduced its Allergan plc (AGN) stake by 97% in Q4 2016, selling an estimated $627K and leaving 78 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #475.

Kanaly Trust first reported a position in AGN in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.18M in Q1 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Kanaly Trust held 78 shares of Allergan plc worth $16K as of Q4 2016.
  • Kanaly Trust sold 3,026 Allergan plc shares in Q4 2016, an estimated $627K.
  • Allergan plc made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #475 holding.
  • Kanaly Trust first reported a position in Allergan plc in Q4 2013 and has held it in 12 quarters since.
  • Kanaly Trust's Allergan plc position peaked at $1.18M in Q1 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.